miRNA作为肺癌中的生物标志物
Esperanza Salcedo Lobera1, Macarena Arroyo Varela2, Rafael Larrosa Jimenez3,4
1U.G.C. Medico-Quirurgica de Enfermedades Respiratorias, Hospital Regional Universitario de Malaga, Malaga, Spain.
Molecular biology reports
|September 23, 2023
概括
微RNAs (miRNAs) 显示为早期肺癌检测和改善患者生存的生物标志物具有前途. 这些通过液体活检获得的小RNA分子提供了一种不那么侵入性的诊断和监测方法.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物标志物发现发现
背景情况:
- 肺癌的死亡率很高,通常是由于晚期诊断和有限的治疗选择.
- 微RNA (miRNA) 是调节基因表达的小RNA分子,与包括癌症在内的各种疾病有关.
- 目前肺癌的诊断方法可能具有侵入性,这凸显了对更少侵入性的替代品的需求.
研究的目的:
- 审查miRNAs作为肺癌生物标志物的重要性.
- 提出证据支持miRNAs在肺癌诊断,治疗和预后中的作用.
- 强调从液体活检中使用miRNA生物标记物的优点.
主要方法:
- 关于miRNAs和肺癌现有研究的文献综述.
- 对调查肺癌患者miRNA表达特征的研究进行分析.
- 评估液体活检对miRNA生物标志物检测的有用性.
主要成果:
- miRNAs是基因表达的关键调节者,在肺癌的发展中起着重要作用.
- 特定的miRNA配置文件与肺癌诊断有关,可以作为诊断生物标志物.
- 液体活检为获得miRNA生物标志物提供了一种最少的侵入性方法,促进了患者的监测.
结论:
- miRNA生物标志物在肺癌的早期诊断和管理方面取得了重大进展.
- 液体活检衍生的miRNA生物标志物为传统活检提供了安全,可访问和可重复的替代方案.
- 对miRNA生物标记物的进一步研究有可能改善肺癌患者的生存率和治疗策略.
相关概念视频
02:39lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K